Reducing Medication Errors on Basis of an Individual Risk Assessment (MERIS1)
Status
Conditions
Treatments
Details and patient eligibility
About
Background:
Medication reviews performed on admission to hospitals reduce medication errors; however, evidence of effect on morbidity and mortality is currently inconsistent. It is known that patients' risks of experiencing medication errors are dependent on both patient- and drug factors, e.g. age, co-morbidity, number of drugs, risk of side effects.
Aim and hypothesis:
The aim of this pilot study is to study acute medical patients' risk of getting a medication error based on an algorithm that takes into account both patient and drug related factors. Secondary, the investigators will explore whether our methods are applicable in a randomised controlled trial. The investigators will also decide the number of patients in a randomised controlled trial based on this pilot study.
The hypothesis is that an algorithm that has already been developed can stratify patients according to their risk of experiencing a medication error.
Methods:
100 acute admitted patients will be risk stratified at admission (>8 hours after). The patients who have highest risks of medication errors will receive a medication review performed by either a clinical pharmacist or a clinical pharmacologist.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Acutely admitted patients
- Age>17 years
Exclusion criteria
- Dying patients
- Suicial patients
Trial design
Primary purpose
Allocation
Interventional model
Masking
100 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal